Price $161.30 |
Market Cap
425.15B
|
Sector Health Care |
Div. Growth
6.00%
|
|
P/E
24.1
|
P/B
6.16
|
P/S
4.81
|
Dividend %
2.60%
|
|
P/CF
135.5
|
P/FCF
36.3
|
Op. Cash Flow
26.11M
|
FCF
4.4
|
|
Op. Margin
22.60%
|
Net Margin
19.90%
|
ROE
27.00%
|
ROI
14.60%
|
|
ROA
10.20%
|
EPS Growth
16.40%
|
Current Ratio
1.2
|
Debt/Equity
51.60%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Bausch Health Companies Inc (BHC) | $28.49 | - | - | 10B | Strong Buy |
| Pressure Biosciences Inc (PBIO) | $2.41 | - | - | 15.9M | Strong Buy |
| Psychemedics Corp. (PMD) | $8.36 | - | - | 46.6M | Strong Buy |
| Recro Pharma Inc (REPH) | $1.85 | - | - | 95.8M | Strong Buy |
| Harvard Bioscience, Inc. (HBIO) | $6.84 | - | - | 284.5M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
